Romidepsin in patients with relapsed of refractory peripheral T-cell lymphoma

Trial Profile

Romidepsin in patients with relapsed of refractory peripheral T-cell lymphoma

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Feb 2014

At a glance

  • Drugs Romidepsin (Primary)
  • Indications Peripheral T-cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Feb 2014 New trial record
    • 10 Dec 2013 Results assessing outcomes in patients aged 60 years or older presented at the 55th Annual Meeting and Exposition of the American Society of Hematology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top